The Uromigos Episode 165: Paper of the Month—ENZAMET Quality of Life Data
Martin Stockler describes the Enzalutamide in First-Line Androgen Deprivation Therapy for Metastatic Prostate Cancer (ENZAMET) trial, which shows mixed effects of enza on QOL in prostate cancer.
670 Madison Ave.
Manalapan, NJ 07726
Contributors and Partners
Cancer Nursing Today
Urban Health Today
Blood Cancers Today
© 2023 Mashup Media, LLC. All rights reserved.